Skip to content
healthcare.dev
Get a free key

Lamivudine

NDC 60505-3250, Lamivudine, tablet, film coated, from Apotex Corp..

Product NDC
60505-3250
Status
Listed
Labeler
Apotex Corp.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA202941
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/60505-3250 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LAMIVUDINE100 mg/1

Pharmacologic classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]

Package NDCNDC-11Package
60505-3250-66050532500660 TABLET, FILM COATED in 1 BOTTLE (60505-3250-6)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/87095352-c088-74b1-7be0-d3e293a90611

  • NADAC price for package 60505325006

    GET /v1/drugs/nadac/60505325006

Use it

Look up 60505-3250 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/60505-3250 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 60505-3250. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.